Bp Plc held its position in Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,000 shares of the company’s stock at the end of the second quarter. Bp Plc’s holdings in Clorox Company (The) were worth $2,132,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. increased its position in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares in the last quarter. Parnassus Investments CA acquired a new position in shares of Clorox Company (The) during the first quarter valued at approximately $434,255,000. Vanguard Group Inc. increased its position in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares in the last quarter. Morgan Stanley increased its position in shares of Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock valued at $134,342,000 after buying an additional 241,210 shares in the last quarter. Finally, WINTON GROUP Ltd increased its position in shares of Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock valued at $28,566,000 after buying an additional 201,737 shares in the last quarter. Hedge funds and other institutional investors own 69.83% of the company’s stock.

Shares of Clorox Company (CLX) opened at 136.30 on Wednesday. The firm has a market capitalization of $17.60 billion, a PE ratio of 25.55 and a beta of 0.40. The company’s 50-day moving average price is $133.40 and its 200 day moving average price is $133.95. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period in the prior year, the company earned $1.30 earnings per share. Clorox Company (The)’s revenue was up 2.9% compared to the same quarter last year. On average, equities analysts forecast that Clorox Company will post $5.67 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This story was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.thecerbatgem.com/2017/08/16/bp-plc-maintains-stake-in-clorox-company-the-clx.html.

CLX has been the subject of several research analyst reports. Jefferies Group LLC initiated coverage on Clorox Company (The) in a research note on Tuesday, April 18th. They set a “hold” rating and a $138.00 target price for the company. Vetr downgraded Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 target price for the company. in a research note on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 target price on Clorox Company (The) and gave the stock a “hold” rating in a research note on Monday, April 24th. BMO Capital Markets reiterated a “buy” rating and set a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Finally, UBS AG reiterated a “sell” rating and set a $121.00 target price (up from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. Clorox Company (The) presently has an average rating of “Hold” and a consensus price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.